Fludarabine in chronic leukaemia.
Astrow
A B
AB
Department of Medicine, Saint Vincent's Hospital and Medical Center of New York, NY, USA.
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017338:Cladribine / Q000737:chemistry; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D015649:Pentostatin / Q000737:chemistry; D011241:Prednisone / Q000008:administration & dosage; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate; D015649:Pentostatin; D017338:Cladribine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone